Clinical Trials on Thromboembolic Disorders in Italy

Total 6018 results

University of Padova

Completed

Screening for Occult Malignancy in Idiopathic Venous Thromboembolism

Venous Thromboembolism

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme Inducers

Atrial Fibrillation | Thromboembolism, Venous

Italy
Arianna Anticoagulazione Foundation

Terminated

Apixaban for Extended Anticoagulation (APIDULCIS) (APIDULCIS)

Venous Thromboembolism | Anticoagulants

Italy
Università degli Studi dell'Insubria

Terminated

D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous Thromboembolism

Venous Thromboembolism

Italy
Arianna Anticoagulazione Foundation

Recruiting

Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) (Jason)

Venous Thromboembolism | Elderly | Anticoagulant

Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna
University of Bologna

Completed

DULCIS (D-dimer and ULtrasonography in Combination Italian Study) (DULCIS)

Venous Thromboembolism

Italy
University Of Perugia

Terminated

PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients (PREVENTIHS)

Venous Thromboembolism | Hemorrhagic Stroke | Deep Venous Thrombosis

Italy
University of Roma La Sapienza

Unknown

Rate of Venous Thrombosis in Acutely Ill Patients Hospitalized in Internal Medicine Wards (AURELIO)

Venous Thromboembolism | Deep Venous Thrombosis

Italy
Università degli Studi dell'Insubria

Terminated

Statins to Reduce D-dimer Levels in Patients With Venous Thrombosis

Hypercholesterolemia | Venous Thromboembolism

Italy
Novartis Pharmaceuticals

Recruiting

Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera (Prospero)

Polycythemia Vera

Italy
University Magna Graecia

Unknown

Multiple Algorithms System Of All Scores in Embolism (MOSE) (MOSE)

Venous Thromboembolism | Risk Assessment | Risk Management

Italy
G. d'Annunzio University

Completed

Venous Thromboembolism and Bleeding in Hospitalized Medical Patients With Cancer

Hemorrhage | Vein Thrombosis

Italy
Pfizer

Completed

S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation (SIFA)

Atrial Fibrillation

Italy
Casa Sollievo della Sofferenza IRCCS
University of Bari

Completed

Distribution of Risk Factors for Venous Thromboembolism in Blood Donors (ANEMONE)

Risk Factor, Cardiovascular | Venous Thromboembolism | Blood Type

Italy
Università degli Studi dell'Insubria

Terminated

Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency

Renal Insufficiency | Medical Patients

Italy
Quovadis Associazione
Azienda Ospedaliera di Padova

Completed

Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19 (VTE-COVID)

COVID-19 Disease | Thromboembolism, Venous

Italy
Fadoi Foundation, Italy
University Of Perugia

Completed

Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer. (PRO-LAPSII)

Prevention of Venous Thromboembolism

Italy
Sanofi

Terminated

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation (BOREALIS-AF)

Atrial Fibrillation

South Africa, Thailand, Chile, Guatemala, Ukraine, United States, Argentina, Australia, Austria, Belarus, Brazil, Bulgaria, Canada, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Greece, India, ... and more
Boehringer Ingelheim

Completed

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Venous Thromboembolism

Italy, Thailand, Russian Federation, Canada, Lithuania, Switzerland
GUALTIERO PALARETI
Arianna Anticoagulazione Foundation

Recruiting

START-Register: Survey on Anticoagulated Patients Register

Atrial Fibrillation | Venous Thromboembolism | Heart Valve Diseases or Prosthesis

Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Completed

D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism

Deep Vein Thrombosis | Pulmonary Embolism

Italy
University of Padova

Completed

Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee Arthroscopy (ERIKA)

Venous Thromboembolism | Haemorrhage

Italy
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Tumor-educated Platelets in Venous Thromboembolism

Neoplasms | Venous Thromboembolism

Spain, Netherlands, Belgium, Italy, Canada, Germany
G. d'Annunzio University

Terminated

Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia (FAITH)

Thrombocytopenia | Medical Patient

Italy
Academisch Medisch Centrum - Universiteit van Amsterdam...
G. d'Annunzio University

Recruiting

Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort Study (REDUCE)

Recurrence | Cancer | Venous Thromboembolism

Spain, Italy, Netherlands
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Italian Federation of Anticoagulation Clinics (FCSA)

Completed

D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of Recurrence

Deep Vein Thrombosis | Pulmonary Embolism

Italy
Gruppo Oncologico Italiano di Ricerca Clinica

Completed

Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy (EDOI)

Cancer | Thromboembolism

Italy
Fadoi Foundation, Italy

Completed

Efficacy of the Use of Risk Scores in Reducing Important Clinical Outcomes in Hospitalized Medical Ill Patients (RICO)

Prevention of Venous Thromboembolism

Italy
London Health Sciences Centre
Ospedale San Raffaele

Completed

Impact of Left Atrial Appendage Exclusion on Short-Term Clinical Outcomes and Long-Term Stroke Incidence

Atrial Fibrillation | Thromboembolism | Cerebrovascular Accident

Italy
iPHNET (italian Pulmonary Hypertension NETwork)

Unknown

CTEPH in Patients With Prior Pulmonary Embolism and Risk Score Validation (CTEPH-SOLUTION)

Pulmonary Embolism | Chronic Thromboembolic Pulmonary Hypertension

Italy
Sanofi

Completed

EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization

Venous Thromboembolism

France, Russian Federation, Spain, Italy, Argentina, Belgium, Brazil, Canada, Colombia, Germany, Israel, Mexico, Poland, United States, Australia, Austria, India, South Africa, United Kingdom, Tunisia
Bayer
Janssen Research & Development, LLC

Completed

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy (XALIA)

Venous Thrombosis | Deep Vein Thrombosis

Switzerland, France, Germany, Hungary, Spain, Sweden, Austria, Czech Republic, Italy, Moldova, Republic of, Slovenia, Ukraine, United Kingdom, Israel, Portugal, Belgium, Denmark, Greece, Netherlands, Canada, Norway
Bayer
Janssen Research & Development, LLC

Completed

Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty (XAMOS)

Venous Thromboembolism

Switzerland, China, Slovakia, France, Germany, Hungary, Korea, Republic of, Singapore, South Africa, Spain, Sweden, Philippines, Australia, Austria, Colombia, Czech Republic, Estonia, Hong Kong, Italy, Latvia, Lebanon, Lithuania, Macedonia... and more
Sanofi

Terminated

Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility (SAVE-VEMED)

Venous Thromboembolism

United States, France, Canada, Romania, Russian Federation, Ukraine, Germany, Italy, Netherlands, Spain, Estonia, India, Czech Republic, Mexico, Hungary, Lithuania, United Kingdom, Korea, Republic of, Australia, Austria, Latvia, New...
Fondazione Policlinico Universitario Agostino Gemelli...
Fondazione Umberto Veronesi

Not yet recruiting

Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) Study (GynCAT)

Gynecologic Cancer | Ovarian Cancer | Venous Thromboembolism | Cervix Cancer | Endometrial Cancer | Vaginal Cancer | Cancer-associated Thrombosis

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism

Lymphoma | Multiple Myeloma | Acute Leukemia | Myelodysplastic Syndrome | Hematologic Neoplasm

Italy
Bayer
Janssen Research & Development, LLC

Completed

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer (COSIMO)

Venous Thrombosis and Pulmonary Embolism

Italy, Germany, United Kingdom, France, Belgium, Canada, Netherlands, Spain, Denmark, Australia
Bayer

Completed

Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis (CONVERT)

Hemodialysis | End-stage Renal Disease | Hemodiafiltration | Prevention of Thromboembolic Events

Spain, Greece, Belgium, Russian Federation, Netherlands, Turkey, Japan, Australia, Austria, Bulgaria, Italy, Ukraine, Czechia, Israel, United States, Hungary, Lithuania, Poland, Portugal
Boehringer Ingelheim

Completed

BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery

Venous Thromboembolism

Austria, Belgium, Czech Republic, Denmark, Finland, France, Hungary, Italy, Netherlands, Norway, South Africa, Sweden
Bayer

Completed

Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement (ODIXaHIP-OD)

Venous Thromboembolism

Italy, Spain, Denmark, Netherlands, Belgium, Austria, Germany, Poland, Sweden, Israel, Norway, United Kingdom, France
Bayer
Janssen Research & Development, LLC

Completed

Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates (Einstein Jr)

Thromboembolism

Spain, Austria, Israel, Italy, France, Turkey, Germany
Boehringer Ingelheim

Completed

Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)

Venous Thromboembolism

United States, Spain, Norway, Canada, Belgium, Thailand, Germany, Turkey, Austria, Hungary, Czechia, Taiwan, Israel, Brazil, Denmark, Italy, Lithuania, Russian Federation, Sweden, Switzerland, Ukraine, Mexico, Greece, Argentina, Finland, ...
Bayer

Completed

Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement (ODIXa-HIP2)

Venous Thromboembolism

Italy, Spain, Denmark, Netherlands, Belgium, Austria, Germany, Poland, Sweden, Israel, France, Norway, United Kingdom
Daiichi Sankyo, Inc.

Completed

Cancer Venous Thromboembolism (VTE)

Cancer | Venous Thromboembolism (VTE) | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE)

United States, Netherlands, Italy, Belgium, France, Hungary
Bayer
Janssen Research & Development, LLC

Completed

EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis (EINSTEINJr)

Venous Thromboembolism

Switzerland, Spain, United States, Austria, Italy, Russian Federation, United Kingdom, Brazil, Australia, Canada, Hungary, Netherlands, Israel, Poland, Japan
Sanofi

Completed

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery (SAVE-HIP1)

Venous Thromboembolism

United States, Canada, Poland, Romania, Russian Federation, Ukraine, Germany, Italy, Spain, Sweden, Turkey, Estonia, India, Philippines, Czech Republic, Mexico, Argentina, Denmark, Finland, Norway, Colombia, Peru, Slovakia, Australia, C... and more
Fadoi Foundation, Italy
University of Perugia, Italy

Unknown

Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer (CARAVAGGIO)

Venous Thromboembolism

United States, Spain, Netherlands, Israel, Italy, Belgium, France, Germany, United Kingdom, Poland, Portugal
Boehringer Ingelheim

Completed

Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty

Venous Thromboembolism

United States, Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, Germany, Hungary, India, Italy, Netherlands, New Zealand, Norway, Poland, South Africa, Spain, Sweden
Daiichi Sankyo, Inc.

Completed

Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study

Deep Vein Thrombosis | Venous Thromboembolism

Spain, United States, United Kingdom, India, France, Canada, Italy, Lebanon, Turkey
Portola Pharmaceuticals

Completed

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) (APEX)

Venous Thromboembolism (VTE)

Belgium, Israel, Italy, United States, France, Bulgaria, Australia, Germany, Russian Federation, Hungary, Singapore, Austria, Chile, Canada, United Kingdom, Czechia, Poland, Spain, Romania, Latvia, South Africa, Croatia, Serbia, Peru, U... and more

Clinical Trials on Thromboembolic Disorders in Italy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations